熱門(mén)詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
美國(guó)Plexera
Plexera 是一家生物科技公司,總部位于美國(guó)西雅圖。Plexera 是國(guó)際先進(jìn)的無(wú)標(biāo)記、高通量、高涵量生物傳感器和生物芯片的全球提供者。我們的宗旨是在全世界范圍內(nèi)為從事生命科學(xué)研究和生產(chǎn)的用戶(hù)提供最先進(jìn)的技術(shù)、儀器和服務(wù),幫助簡(jiǎn)化與加速治療性蛋白質(zhì)的發(fā)現(xiàn)、生物標(biāo)記物的發(fā)現(xiàn)以及新藥開(kāi)發(fā)的進(jìn)程。 Plexera 的產(chǎn)品主要包括生物分子相互作用分析系統(tǒng)與生物芯片,二者的組合可以為功能蛋白質(zhì)組學(xué)研究提供最佳解決方案。
Plexera 系統(tǒng)采用表面等離子共振技術(shù)分析生物分子間的相互作用,向研究者提供高質(zhì)量的動(dòng)力學(xué)、親和力以及特異性的信息,產(chǎn)品核心技術(shù)涵蓋光、電、機(jī)、化學(xué)、生物和納米技術(shù)。我們?cè)诿绹?guó)哈弗大學(xué)醫(yī)學(xué)院、系統(tǒng)生物學(xué)研究所、Baylor免疫研究所等世界著名研究機(jī)構(gòu)完成了儀器的第三方測(cè)試,并開(kāi)展了與國(guó)際知名制藥公司、生物科技公司的應(yīng)用合作。Plexera 系列產(chǎn)品以其優(yōu)秀的性能博得了業(yè)內(nèi)人士的高度評(píng)價(jià)與青睞。
?
Plexera? Bioscience manufactures high throughput Surface Plasmon Resonance (SPR) instruments providing the life sciences market with tools, content, and methods that simplify and accelerate required steps in the drug discovery and development process.
The study of proteomics presents researchers with costly analytical challenges due to the complexity and size of individual proteomes. When you consider the number of biologic interactions, the complexity grows exponentially. Researchers’ need for information has outpaced currently available technology. KX Array? Technology developed by Plexera Bioscience addresses this complexity and the need for more information by combining label free, real-time detection methods with microarray based, high density assay formats. KX Array Technology utilizes Surface Plasmon Resonance, which provides a cost effective, high throughput solution for detecting and quantifying the binding and concentration of thousands of proteins in a single experiment.
Market applications target biomarker screening and discovery, biomolecular interactions of genomic materials and drug interactions. The bench scientist seeking new targets, pharmacologists seeking the pharmaco-dynamics of a drug or clinicians determining the efficacy of a drug, will all benefit from the information derived from the use of the Plexera platform.
Plexera? Bioscience has opened a manufacturing and development site in Woodinville, Washington, 15 miles north of Seattle and an application and engineering site in Beijing, China.
Plexera? LLC maintains several collaborative relationships both in the US and in Asia with leading Academic and Research institutions.
?